266.57

3.90% 10.01

Insulet Corporation (PODD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché PODD Giù? Forum Previsione

Precedente Chiudi:

$256.56

Aprire:

$256.56

Volume 24 ore:

1.18M

Relative Volume:

2.15

Capitalizzazione di mercato:

$18.70B

Reddito:

$1.98B

Utile/perdita netta:

$420.90M

Rapporto P/E:

155.89

EPS:

1.71

Flusso di cassa netto:

$218.20M

1 W Prestazione:

-1.03%

1M Prestazione:

-0.00%

6M Prestazione:

+33.75%

1 anno Prestazione:

+28.18%

Intervallo 1D:

$256.56

$270.70

Intervallo di 1 settimana:

$254.79

$271.18

Portata 52W:

$160.19

$279.77

Insulet Corporation Stock (PODD) Company Profile

Nome

Insulet Corporation

Settore

Healthcare (1176)

Industria

Medical Devices (148)

Telefono

978-600-7000

Indirizzo

100 NAGOG PARK, ACTON, MA

Dipendente

3,000

Cinguettio

@insulet_uk

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

PODD's Discussions on Twitter

Confronta PODD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PODD Insulet Corporation	266.57	18.70B	1.98B	420.90M	218.20M	5.84
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-06	Iniziato	Bernstein	Outperform
2024-05-30	Iniziato	Redburn Atlantic	Buy
2024-05-07	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2023-12-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2023-12-04	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-10-02	Aggiornamento	Jefferies	Hold → Buy
2023-08-21	Aggiornamento	Citigroup	Neutral → Buy
2023-08-21	Downgrade	Robert W. Baird	Outperform → Neutral
2023-05-30	Ripresa	Morgan Stanley	Equal-Weight
2023-01-26	Iniziato	Wolfe Research	Peer Perform
2022-11-04	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-10-18	Iniziato	Barclays	Equal Weight
2022-10-12	Iniziato	Jefferies	Hold
2022-07-11	Downgrade	Citigroup	Buy → Neutral
2022-03-02	Ripresa	BofA Securities	Buy
2022-02-03	Aggiornamento	BTIG Research	Neutral → Buy
2022-02-02	Aggiornamento	UBS	Neutral → Buy
2022-01-31	Aggiornamento	Oppenheimer	Perform → Outperform
2021-07-21	Ripresa	Cowen	Outperform
2021-05-25	Iniziato	Barclays	Overweight
2021-04-01	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-03-19	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-01-29	Downgrade	Piper Sandler	Overweight → Neutral
2020-12-16	Downgrade	Citigroup	Buy → Neutral
2020-07-28	Iniziato	Wells Fargo	Overweight
2020-04-24	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-04-03	Iniziato	BofA/Merrill	Neutral
2020-03-31	Downgrade	Berenberg	Buy → Hold
2020-03-05	Iniziato	Citigroup	Buy
2019-12-10	Iniziato	CFRA	Sell
2019-10-23	Iniziato	Stifel	Hold
2019-10-18	Downgrade	Canaccord Genuity	Buy → Hold
2019-10-14	Downgrade	BTIG Research	Buy → Neutral
2019-10-04	Downgrade	UBS	Buy → Neutral
2019-10-03	Downgrade	Guggenheim	Buy → Neutral
2019-08-06	Aggiornamento	JP Morgan	Neutral → Overweight
2019-06-10	Downgrade	Northland Capital	Outperform → Market Perform
2019-05-06	Aggiornamento	BTIG Research	Neutral → Buy
2018-04-20	Iniziato	Berenberg	Buy
2018-02-22	Reiterato	Barclays	Overweight
2018-01-08	Aggiornamento	Raymond James	Mkt Perform → Outperform
2017-11-03	Aggiornamento	Canaccord Genuity	Hold → Buy
2017-09-15	Iniziato	Barclays	Overweight

Mostra tutto

Insulet Corporation Borsa (PODD) Ultime notizie

Dec 20, 2024

Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 19, 2024

Dec 18, 2024

Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly - Simply Wall St

Dec 18, 2024

Dec 17, 2024

Insulet corp EVP Benjamin Eric sells $1.17 million in shares By Investing.com - Investing.com Australia

Dec 17, 2024

Insulet corp EVP Benjamin Eric sells $1.17 million in shares - Investing.com India

Dec 17, 2024

Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga

Dec 17, 2024

Stocks Fall As Breadth Remains Weak; Fortinet, Insulet, Embraer In FocusVideoIBD - Investor's Business Daily

Dec 17, 2024

Dec 15, 2024

Virtu Financial LLC Makes New $616,000 Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 15, 2024

Toronto Dominion Bank Buys 3,117 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 15, 2024

Dec 14, 2024

Insulet Co. (NASDAQ:PODD) Stake Raised by Geode Capital Management LLC - MarketBeat

Dec 14, 2024

Dec 13, 2024

Insulet's SWOT analysis: tubeless pump maker's stock faces competition - Investing.com

Dec 13, 2024

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Dec 13, 2024

Insulet Co. (NASDAQ:PODD) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat

Dec 13, 2024

Orion Portfolio Solutions LLC Purchases 3,623 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 13, 2024

Dec 12, 2024

Insulet stock soars to 52-week high, reaching $279.42 - Investing.com India

Dec 12, 2024

RMD or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance

Dec 12, 2024

Insulet stock soars to 52-week high, reaching $279.42 By Investing.com - Investing.com UK

Dec 12, 2024

National Bank of Canada FI Decreases Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 12, 2024

Dec 11, 2024

Insulet corp executive sells $252,192 in common stock By Investing.com - Investing.com Nigeria

Dec 11, 2024

Insulet corp executive sells $252,192 in common stock - Investing.com India

Dec 11, 2024

Should You Continue to Retain Insulet Stock in Your Portfolio Now? - MSN

Dec 11, 2024

Tandem Diabetes (TNDM) and Insulet (PODD) Volatility Attributed to Channel-Check Firm - StreetInsider.com

Dec 11, 2024

Dec 10, 2024

Google Takes Quantum Leap But Growth Weak Again; AppLovin, Insulet In Focus TooVideoIBD - Investor's Business Daily

Dec 10, 2024

Quantinno Capital Management LP Acquires 7,270 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 10, 2024

Insulet Co. (NASDAQ:PODD) Shares Bought by Nomura Asset Management Co. Ltd. - MarketBeat

Dec 10, 2024

Dec 09, 2024

3,459 Shares in Insulet Co. (NASDAQ:PODD) Purchased by SGL Investment Advisors Inc. - MarketBeat

Dec 09, 2024

Insulet Co. (NASDAQ:PODD) Position Trimmed by Groupama Asset Managment - MarketBeat

Dec 09, 2024

XTX Topco Ltd Acquires Shares of 6,351 Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 09, 2024

Dec 07, 2024

Insulet successfully defends its Intellectual property against EOFlow - Medical Buyer

Dec 07, 2024

Dec 06, 2024

Insulet wins $452M in lawsuit against rivals over medical device trade secrets - Cardiovascular Business

Dec 06, 2024

Dec 05, 2024

Jury awards Insulet $452M against Eoflow in trade secrets case - BioWorld Online

Dec 05, 2024

Insulet wins $452M in trade secret case By Investing.com - Investing.com Australia

Dec 05, 2024

Insulet Wins $452M Trade Secrets Verdict Against EOFlow - USA Herald

Dec 05, 2024

Readystate Asset Management LP Trims Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 05, 2024

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters

Dec 05, 2024

Insulet Wins $452M Jury Verdict in Trade Secrets Battle with EOFlow - USA Herald

Dec 05, 2024

Insulet awarded $452M in EOFlow patent fight - MedTech Dive

Dec 05, 2024

Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial - Bloomberg Law

Dec 05, 2024

Insulet's Legal Win Against EOFlow Over Trade Secret Theft - Finimize

Dec 05, 2024

BREAKING: Insulet Corp. Wins $452M In Trade Secret Theft Trial - Law360

Dec 05, 2024

Insulet Wins $452 Million Trade Secret Victory Against EOFlow - MPO-mag

Dec 05, 2024